ArticleClinical medicine & research2022

Determinants of Atrial Fibrillation Development among Patients undergoing Ibrutinib Therapy.

Adedayo A Onitilo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.